Target 879 ( 1 to 5 months )Good Technical and Funcamental So target 879 , Duration 1 to 5 months.....
27.85 INR
237.96 M INR
3.07 B INR
2.35 M
About KWALITY PHARMACEUTICALS LIMITE
Sector
CEO
Ramesh Arora
Headquarters
Amritsar
Website
Founded
1983
ISIN
INE552U01010
FIGI
BBG00D786M92
Kwality Pharmaceuticals Ltd. engages in the manufacture of pharmaceutical formulations in dosage form. Its products includes tablets, bolus, liquid orals, sterile powder for injection, ointments, ophthalmic, capsules, liquid injections, dry powder for oral suspension, and external preparation. The company was founded by Ramesh Arora on May 4, 1983 and is headquartered in Amritsar, India.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of KPL is 924.85 INR — it has increased by 5.00% in the past 24 hours. Watch KWALITY PHARMACEUTICALS LIMITE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange KWALITY PHARMACEUTICALS LIMITE stocks are traded under the ticker KPL.
KPL stock has risen by 9.42% compared to the previous week, the month change is a 34.24% rise, over the last year KWALITY PHARMACEUTICALS LIMITE has showed a 174.97% increase.
KPL stock is 6.67% volatile and has beta coefficient of 0.67. Track KWALITY PHARMACEUTICALS LIMITE stock price on the chart and check out the list of the most volatile stocks — is KWALITY PHARMACEUTICALS LIMITE there?
Today KWALITY PHARMACEUTICALS LIMITE has the market capitalization of 9.76 B, it has increased by 5.90% over the last week.
Yes, you can track KWALITY PHARMACEUTICALS LIMITE financials in yearly and quarterly reports right on TradingView.
KPL net income for the last quarter is 84.70 M INR, while the quarter before that showed 83.56 M INR of net income which accounts for 1.36% change. Track more KWALITY PHARMACEUTICALS LIMITE financial stats to get the full picture.
No, KPL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 8, 2024, the company has 806.00 employees. See our rating of the largest employees — is KWALITY PHARMACEUTICALS LIMITE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KWALITY PHARMACEUTICALS LIMITE EBITDA is 743.14 M INR, and current EBITDA margin is 22.67%. See more stats in KWALITY PHARMACEUTICALS LIMITE financial statements.
Like other stocks, KPL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KWALITY PHARMACEUTICALS LIMITE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KWALITY PHARMACEUTICALS LIMITE technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KWALITY PHARMACEUTICALS LIMITE stock shows the buy signal. See more of KWALITY PHARMACEUTICALS LIMITE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.